Posts tagged “Biotech & Life Science”
Billionaire David Murdock, the founder of the North Carolina Research Campus in Kannapolis, and an executive at Dole Food have been ordered to pay $148 million in a dispute over Murdock's buyout of that company in 2013. The judge says Dole directors and shareholders were mislead in the deal.
When a chorus of cheers accompanies announcements like the $1.85 billion Novo Nordisk expansion in Clayton, the echo is a reminder: it only happens because a lot of behind-the-scenes work quietly makes it possible.
Mayne Pharma, which already operates a big production plant in Greenville, is going to add as many as 110 jobs as part of a $65 million expansion plan. Jobs include scientists, manufacturing and other positions. It's the second big life science expansion announced in N.C. this week.
The Food and Drug Administration has released its proposal for naming lower-cost biotech drugs, a critical step in creating a market for the new class of medicines called "biosimilars." Plus: Read the full statement from the FDA.
Facebook testing own Siri; Windows 10 on 75M devices; Ashley Madison lawsuits; booze in space; diabetes drug cuts complications
In today's Bulldog wrapup of technology and life science news: Facebook is testing its own digital assistant; Microsoft says Windows 10 now on 75 million machines; Ashley Madison faces lawsuits after hack; booze arrives at the international space station; and for the first time a diabetes drug is said to be cutting complications associated with the disease.
Clayton and Johnston County celebrated a big win in the competition for high-paying jobs Wednesday when Novo Nordisk announced plans to expand its plant there by almost 700 employees.
Novo Nordisk is expanding its drug-making presence in Johnston County with a facility that will add 691 jobs. The average wage will be $68,420. Novo Nordisk plans to invest $1.2 billion in the new facility. The state commits more than $18 million in incentives to the project.
State and county executives are expected to announcement a big economic development project that will create "several hundred full-time" jobs in Johnston County. And WRAL TechWire is told that the deal is with a life science company.
One-on-one with Christy Shaffer: What Hatteras' new $90M fund means, impact of her promotion; and why Triangle life science sector is so hot
In a Q&A, Triangle veteran life science executive turned venture capitalist Christy Shaffer talks with WRAL TechWire about the new $90 million venture fund raised by Hatteras Ventures, what her promotion says about female VCs, and why the Triangle life science sector is so hot.
Pfizer-Hospira deal nears close; Lenovo phones No. 1 in India; Cortona goes Android; Facebook guilty 'spam' plea; driverless crash truck
In today's Bulldog wrapup of technology and life science news: The Pfizer-Hospira deal nears a close; Lenovo is No. 1 in 4g smartphones across India; Microsoft offers beta on Cortana for Android; a guilty please in a Facebook spam case; and a driverless crash truck debuts.
Triangle tech calendar: Raleigh Startup Crawl, Innovate Raleigh, Jim Whitehurst, WTW's Internet of Things
August wraps with a bang - Jim Whitehurst of Red Hat's leadership talk - then September brings a host of events: Innovate Raleigh, the Startup Crawl, CED's Tech Venture, WRAL TechWire's Internet of Things event - and much more. Check out the highlights.
WRALTechWire is continuously expanding its content lineup, and we want you to participate. We are looking for news and analysis about all things tech and life science from people who know their business.
Want proof that life science startups and emerging firms are back as targets for investment capital? Raleigh's Sprout Pharmaceuticals is being sold for $1 billion and RTP startup AgBiome has raised an impressive $34.5 million. But these aren't the only indicators that VCs and private equity see biotech and pharmaceuticals as good bets once again.
So Raleigh's Sprout Pharmaceuticals sells itself for $1 billion plus royalties in the future within 48 hours of winning approval for its "little pink pill" - is this a Jackie and the beanstalk story with success sprouting overnight? By the way, initial reaction on Wall Street to Valeant's buy is very negative.
Only two years after it raised $17.5 million in venture capital, AgBiome of Research Triangle Park announced today it has raised an additional $34.5 million to fund research and the projected launch of its first product, a natural fungicide for crops and turf grasses. Yes, the RTP startup is growing fast.
GlaxoSmithKline has struck another major deal with Novartis. This time the drug giants are teaming up for a deal worth more than $1 billion plus royalties to GSK for an experimental multiple sclerosis drug. The deal will help GSK focus on other priorities, a top executive says.